Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 |
filingDate |
1996-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fed5ffc68c40929e9edfe879897d18c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbf8d04e03875d1b6dcea8bcef8c6304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d111baee8892e99d3a00298961089972 |
publicationDate |
1998-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
FR-2756733-A1 |
titleOfInvention |
USE OF MELATONIN OR ANALOGS THEREOF TO INHIBIT PIGMENTATION OF HUMAN SKIN INDUCED BY ALPHA-MSH |
abstract |
The present invention relates to the use of melatonin or its analogues to inhibit the pigmentation of human skin induced by alpha-MSH. The present invention also relates to a cosmetic treatment process for human skin intended to maintain the basal color of the skin, in which a topical composition containing melatonin or its analogues is applied to the skin. |
priorityDate |
1996-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |